Advertisement

Ads Placeholder
Loading...

Irwin Naturals Inc.

IWINFPNK
Healthcare
Medical - Pharmaceuticals
$0.50
$0.17(51.52%)
U.S. Market opens in 50h 42m

Irwin Naturals Inc. Fundamental Analysis

Irwin Naturals Inc. (IWINF) shows weak financial fundamentals with a PE ratio of -0.18, profit margin of -4.46%, and ROE of -21.19%. The company generates $0.2B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position111.79%
PEG Ratio-0.00

Areas of Concern

ROE-21.19%
Operating Margin2.06%
We analyze IWINF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -17.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-17.9/100

We analyze IWINF's fundamental strength across five key dimensions:

Efficiency Score

Weak

IWINF struggles to generate sufficient returns from assets.

ROA > 10%
-5.07%

Valuation Score

Excellent

IWINF trades at attractive valuation levels.

PE < 25
-0.18
PEG Ratio < 2
-0.00

Growth Score

Weak

IWINF faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

IWINF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.92
Current Ratio > 1
1.24

Profitability Score

Weak

IWINF struggles to sustain strong margins.

ROE > 15%
-2119.06%
Net Margin ≥ 15%
-4.46%
Positive Free Cash Flow
No

Key Financial Metrics

Is IWINF Expensive or Cheap?

P/E Ratio

IWINF trades at -0.18 times earnings. This suggests potential undervaluation.

-0.18

PEG Ratio

When adjusting for growth, IWINF's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Irwin Naturals Inc. at 0.03 times its book value. This may indicate undervaluation.

0.03

EV/EBITDA

Enterprise value stands at -12.30 times EBITDA. This is generally considered low.

-12.30

How Well Does IWINF Make Money?

Net Profit Margin

For every $100 in sales, Irwin Naturals Inc. keeps $-4.46 as profit after all expenses.

-4.46%

Operating Margin

Core operations generate 2.06 in profit for every $100 in revenue, before interest and taxes.

2.06%

ROE

Management delivers $-21.19 in profit for every $100 of shareholder equity.

-21.19%

ROA

Irwin Naturals Inc. generates $-5.07 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.07%

Following the Money - Real Cash Generation

Operating Cash Flow

Irwin Naturals Inc. generates limited operating cash flow of $-14.99M, signaling weaker underlying cash strength.

$-14.99M

Free Cash Flow

Irwin Naturals Inc. generates weak or negative free cash flow of $-15.33M, restricting financial flexibility.

$-15.33M

FCF Per Share

Each share generates $-4.55 in free cash annually.

$-4.55

FCF Yield

IWINF converts -3.87% of its market value into free cash.

-3.87%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.18

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.03

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.02

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.92

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.24

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.21

vs 25 benchmark

ROA

Return on assets percentage

-0.05

vs 25 benchmark

ROCE

Return on capital employed

0.05

vs 25 benchmark

How IWINF Stacks Against Its Sector Peers

MetricIWINF ValueSector AveragePerformance
P/E Ratio-0.1828.45 Better (Cheaper)
ROE-21.19%763.00% Weak
Net Margin-4.46%-45265.00% (disorted) Weak
Debt/Equity0.920.34 Weak (High Leverage)
Current Ratio1.242795.60 Neutral
ROA-5.07%-16588.00% (disorted) Weak

IWINF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Irwin Naturals Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ